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Case Report
Introduction
Atypical ductal hyperplasia (ADH) of the breast is a term given
to the histopathological entity in a proposed malignant
progression where hyperplastic ductal epithelium begins to
acquire histological as well as biological characteristics of
ductal carcinoma in situ (DCIS).1 Long-term follow-up studies
show that women with ADH have approximately five times
greater risk of developing invasive breast cancer than women
who have ductal hyperplasia but lack atypia.2,3
The defining line between ADH and DCIS is problematical.
A size criterion for ADH was introduced in 1990 to separate
lesions that have cytological and architectural features of low-
grade DCIS and into ADH versus DCIS classification.1 Despite
refinements in histological classification and distinction
between DCIS and ADH, a clinical dilemma still arises when
multiple foci of these pathologies arise. Extremes of surgical
management can equally be defended from surveillance to
bilateral prophylactic mastectomy, as well as a more “middle
ground” approach with chemoprophylaxis. The problem is
complicated in younger patients who have a potentially lengthy
follow-up, and where breast monitoring by imaging is limited
by current technologies. We report two cases demonstrating
the management of these borderline lesions.
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Atypical Ductal Hyperplasia of the Breast in Young
Women: Two Case Reports
Case One
A 16-year-old Caucasian girl underwent bilateral breast
reduction mammoplasty for juvenile hypertrophy. Her bra
size had increased to size double D cup between the ages of
12 and 16. She underwent menarche at age 13. There were no
risk factors for breast cancer.
The surgical specimens (right breast, 455 g and left breast,
465 g), were sent for routine histology. In the left breast
specimen only, multiple foci of ADH were found (Figure 1).
The patient underwent subsequent mammography and
ultrasound revealing no foci of breast cancer and no suspicious
abnormalities. The patient’s female relatives were also screened.
It was estimated that the malignant potential of the lesion
found was approximately 10% over 10 years. With no family
history, it was estimated that the patient’s chance of carrying
an inherited germ-line mutation of either BRCA1 or BRCA2
genes was less than 5%.
The patient went on to have ipsilateral mastectomy and
immediate prosthetic reconstruction. In the mastectomy
specimen, multiple residual foci of ADH were found. She
has been monitored with physical examination, ultrasound
and contralateral mammography for 4 years without
incident.
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Atypical ductal hyperplasia of the breast is a benign proliferative condition that is associated with an increased
risk of development of breast cancer in either the ipsilateral or contralateral breast. Following diagnosis at biopsy,
respective management options range from observation to chemoprophylaxis to prophylactic surgery. We
present two cases in young women, facing prolonged follow-up, one managed with observation only, and the
other managed with ipsilateral mastectomy and reconstruction. (Asian J Surg 2003;26(1):37–9)
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Case Two
A 24-year-old Chinese patient presented with a left breast
lump. Mammography and ultrasound revealed microcalci-
fications in the left breast, in the region of her lump. Fine
needle aspiration biopsy showed benign cells. Subsequent
wire-localized biopsy showed luminal calcification, blunt duct
adenosis, some fibroadenomatoid hyperplasia, and a small
focus of ADH (Figure 2). It was thought that the calcification
was unrelated to the atypical hyperplasia.
The patient has now been monitored for 6 years, has
undergone subsequent pregnancies, and has no sign of any
further trouble in the breast as assessed by clinical examination
and ultrasound.
Discussion
The incidence of breast cancer before age 30 is approximately
1/2,000.4,5 ADH, though closely related histologically to DCIS
has a different natural history. DCIS will progress to ipsilateral
breast cancer in approximately 25% to 50% of cases over the
course of 10 years.6 Conversely, ADH increases the risk of
either ipsi- or contralateral breast cancer during the next 10
years, with a peak incidence in the 3rd decade.2 The presence of
a positive family history increases the risk two-fold.
The mode of diagnosis in the first patient was at reduction
mammoplasty. Breast cancer in reduction mammoplasty is
made in 0.16% of reduction mammoplasties performed, and
was the mode of diagnosis in five of nine young women with
ADH described by Eliason et al.7 Routine histopathological
examination is recommended for all reduction mammoplasty
specimens.8
In the second patient, the mode of diagnosis was at core
biopsy mandating further excision, as approximately 30% of
patients in this situation have occult invasive carcinoma at
open biopsy.9
The options for any high-risk patient for developing
breast cancer include surveillance, chemoprophylaxis with
tamoxifen, or prophylactic ablative surgery with bilateral
mastectomy.
In the first patient, the decision to proceed with prophylactic
mastectomy was governed by the fact that the patient had
apparently separate but multiple foci of atypical hyperplasia.
This blurred the “size criterion” definition of ADH. An ipsilater-
al prophylactic mastectomy, therefore, seemed a reasonable
option, with this diagnostic uncertainty. The immediate
reconstruction had no oncological significance but, in a
teenager, it was considered important in respect to body image.
It is estimated that her chance of developing breast cancer in
the ipsilateral breast has now been reduced by 90%.10
The decision of the second patient to undergo surveillance
only was based on the small amount of disease and the natural
history of the condition. This management plan has some
potential pitfalls, notably to do with adequately monitoring
patients in their third decade. Mammography is less specific,
and paradoxically may lead to more “false positive” studies
with benign lesions requiring further investigation, such as in
this case, which began with investigation of stromal
calcification that was of no significance in itself, the ADH
being an incidental finding.
Figure 1. Haematoxylin and eosin stained section of the mastectomy
specimen of patient 1, a 16-year-old Caucasian girl. The epithelial
hyperplasia within this ductal space has a cribriform pattern.
Figure 2. Haematoxylin and eosin stained section of the specimen
of patient 2, a 24-year-old Chinese woman. The epithelial hyperplasia
has a cribriform pattern, similar to that of patient 1.
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